In contrast, Figures 4 and 5 reveal trends, albeit not statistically significant, which suggest that the cytoplasmic localisation of Total-AKT1, P-AKT and SHARP-2 may increase with tumour development and/or progression. Here, AKT1 is linked to neoplasm.